- Joined
- Aug 5, 2007
- Messages
- 977
So here's some questions about CJC 1295 DAC. It involves a matter of financial trade-offs.
_____________
Question 1:
Assume that a researcher has a fixed budget per week for researching GHRH and/or GHRP peptides... let's say he has $50/week. For this question, also assume that his goal is to maximize muscle gains and fat loss in his research subject.
Now, for a budget of $50/week, would it be MOST advantageous for him to allocate that $50 entirely towards CJC-1295 DAC? (Something like CJC DAC (@4mg) per week)
Or
Should he allocate his $50 among GHRH and GHRP? (Something like CJC-1295 DAC (@2mg) + GHRP-6 throughout the week?)
__________________________________
Now, for question #2.
Let's say a researcher increases his fixed budget to $100/week. Do the ratios change?
For example, would he best off to run 8mg of CJC per week with no GHRPs?
Or would he want 4mg of CJC, with the rest spent on additional GHRPs?
Or would he want 2mg of CJC, with the rest spent on additional GHRPs?
The reason I pose this question is because I would like to understand how it is most wise to allocate dollars towards these products to optimize the gains in the subject. (Cost constraints become increasingly important in long-term research)
I have read that some researchers prefer high doses of CJC-1295 DAC by itself, with no GHRPs. Others say there is a synergistic effect when combining a medium amount of CJC-1295 DAC with an appropriate amount of GHRPs. The question is, which one is best, when considering cost constraints?
_____________
Question 1:
Assume that a researcher has a fixed budget per week for researching GHRH and/or GHRP peptides... let's say he has $50/week. For this question, also assume that his goal is to maximize muscle gains and fat loss in his research subject.
Now, for a budget of $50/week, would it be MOST advantageous for him to allocate that $50 entirely towards CJC-1295 DAC? (Something like CJC DAC (@4mg) per week)
Or
Should he allocate his $50 among GHRH and GHRP? (Something like CJC-1295 DAC (@2mg) + GHRP-6 throughout the week?)
__________________________________
Now, for question #2.
Let's say a researcher increases his fixed budget to $100/week. Do the ratios change?
For example, would he best off to run 8mg of CJC per week with no GHRPs?
Or would he want 4mg of CJC, with the rest spent on additional GHRPs?
Or would he want 2mg of CJC, with the rest spent on additional GHRPs?
The reason I pose this question is because I would like to understand how it is most wise to allocate dollars towards these products to optimize the gains in the subject. (Cost constraints become increasingly important in long-term research)
I have read that some researchers prefer high doses of CJC-1295 DAC by itself, with no GHRPs. Others say there is a synergistic effect when combining a medium amount of CJC-1295 DAC with an appropriate amount of GHRPs. The question is, which one is best, when considering cost constraints?
Last edited: